Cited by 488Pancreatic function and diabetesAlzheimer's disease research and treatmentsDiabetes Treatment and Management

The DOI matches its Crossref record.

Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes.

Kahn, S E, Andrikopoulos, S, Verchere, C B·1999·Diabetes

DOI 10.2337/diabetes.48.2.241

Open this paper in CoChat — free account

Abstract

Islet amyloid has been recognized as a pathological entity in type 2 diabetes since the turn of the century. It has as its unique component the islet beta-cell peptide islet amyloid polypeptide (IAPP), or amylin, which is cosecreted with insulin. In addition to this unique component, islet amyloid contains other proteins, such as apolipoprotein E and the heparan sulfate proteoglycan perlecan, which are typically observed in other forms of generalized and localized amyloid. Islet amyloid is observed at pathological examination in the vast majority of individuals with type 2 diabetes but is rarely observed in humans without disturbances of glucose metabolism. In contrast to IAPP from rodents, human IAPP has been shown to form amyloid fibrils in vitro. Because all human subjects produce and secrete the amyloidogenic form of IAPP, yet not all develop islet amyloid, some other factor(s) must be involved in islet amyloid formation. One hypothesis is that an alteration in beta-cell function resulting in a change in the production, processing, and/or secretion of IAPP is critical to the initial formation of islet amyloid fibrils in human diabetes. This nidus of amyloid fibrils then allows the progressive accumulation of IAPP-containing fibrils and the eventual replacement of beta-cell mass by amyloid and contributes to the development of hyperglycemia. One factor that may be involved in producing the changes in the beta-cell that result in the initiation of amyloid formation is the consumption of increased dietary fat. Dietary fat is known to alter islet beta-cell peptide production, processing, and secretion, and studies in transgenic mice expressing human IAPP support the operation of this mechanism. Further investigation using this and other models should provide insight into the mechanism(s) involved in islet amyloidogenesis and allow the development of therapeutic agents that inhibit or reverse amyloid fibril formation, with the goal being to preserve beta-cell function and improve glucose control in type 2 diabetes.

Integrity signals

Registry

Crossref · 10.2337/diabetes.48.2.241

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Still being checked.

Sorted by citations

Items 101–200 of 488

IAPP in type II diabetes: Basic research on structure, molecular interactions, and disease mechanisms suggests potential intervention strategies
Asthana, S., Mallick, B., Alexandrescu, A. T., & Jha, S. (2018) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2018.02.020 · Cited by 96
Rifampicin Does Not Prevent Amyloid Fibril Formation by Human Islet Amyloid Polypeptide but Does Inhibit Fibril Thioflavin-T Interactions: Implications for Mechanistic Studies of β-Cell Death
Meng, F., Marek, P., Potter, K. J., Verchere, C. B., & Raleigh, D. P. (2008) · Biochemistry · doi:10.1021/bi702518m · Cited by 93
Self-citation
The prevention of type 2 diabetes — lifestyle change or pharmacotherapy? A challenge for the 21st century
Simpson, R. W., Shaw, J. E., & Zimmet, P. (2003) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(02)00275-9 · Cited by 92
The Association of Heart Failure With Insulin Resistance and the Development of Type 2 Diabetes
Kostis, J. B., & SANDERS, M. (2005) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2004.11.038 · Cited by 93
β-cell apoptosis in type 2 diabetes: quantitative and functional consequences
Lupi, R., & Prato, S. D. (2008) · Diabetes & Metabolism · doi:10.1016/s1262-3636(08)73396-2 · Cited by 90
Identification of minimal peptide sequences in the (8–20) domain of human islet amyloid polypeptide involved in fibrillogenesis
Scrocchi, L. A., Ha, K., Chen, Y., Wu, L., Wang, F., & Fraser, P. E. (2003) · Journal of Structural Biology · doi:10.1016/s1047-8477(02)00630-5 · Cited by 87
Efficient Microwave-Assisted Synthesis of Human Islet Amyloid Polypeptide Designed to Facilitate the Specific Incorporation of Labeled Amino Acids
Marek, P., Woys, A. M., Sutton, K., Zanni, M. T., & Raleigh, D. P. (2010) · Organic Letters · doi:10.1021/ol101981b · Cited by 86
Mechanistic Studies of Peptide Self-Assembly: Transient α-Helices to Stable β-Sheets
Liu, G., Prabhakar, A., Aucoin, D., Simon, M., Sparks, S., Robbins, K. J., Sheen, A., Petty, S. A., & Lazo, N. D. (2010) · Journal of the American Chemical Society · doi:10.1021/ja1069882 · Cited by 87
Naturally Occurring and Experimental Diabetes in Cynomolgus Monkeys: A Comparison of Carbohydrate and Lipid Metabolism and Islet Pathology
Wagner, J. D., Cline, J. M., Shadoan, M. K., Bullock, B. C., Rankin, S. E., & Cefalu, W. T. (2001) · Toxicologic Pathology · doi:10.1080/019262301301418955 · Cited by 85
Sensitivity of Amyloid Formation by Human Islet Amyloid Polypeptide to Mutations at Residue 20
Cao, P., Tu, L., Abedini, A., Levsh, O., Akter, R., Patsalo, V., Schmidt, A. M., & Raleigh, D. P. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.12.032 · Cited by 85
Role of islet β cell autophagy in the pathogenesis of diabetes
Lee, M. (2014) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2014.08.005 · Cited by 83
Natural Substrates of Dipeptidyl Peptidase IV
Meester, I. D., Durinx, C., Bal, G., Proost, P., Struyf, S., Goossens, F. J., Augustyns, K., & Scharpé, S. (2002) · Advances in experimental medicine and biology · doi:10.1007/0-306-46826-3_7 · Cited by 84
Amyloid inhibitors enhance survival of cultured human islets
Potter, K. J., Scrocchi, L. A., Warnock, G. L., Ao, Z., Younker, M. A., Rosenberg, L. C., Lipsett, M. A., Verchere, C. B., & Fraser, P. E. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.02.013 · Cited by 84
Self-citation
Protein aggregation in Escherichia coli: role of proteases
Rosen, R., Biran, D., Gur, E., Becher, D., Hecker, M., & Ron, E. Z. (2002) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2002.tb11020.x · Cited by 83
Prion-like aggregates: infectious agents in human disease
Westermark, G. T., & Westermark, P. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.08.004 · Cited by 84
Concentration‐dependent transitions govern the subcellular localization of islet amyloid polypeptide
Magzoub, M. M., & Miranker, A. D. (2011) · The FASEB Journal · doi:10.1096/fj.11-194613 · Cited by 82
RAGE binds preamyloid IAPP intermediates and mediates pancreatic β cell proteotoxicity
Abedini, A., Cao, P., Plesner, A., Zhang, J., He, M., Derk, J., Patil, S. A., Rosario, R., Lonier, J., Song, F., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci85210 · Cited by 83
Estrogen Can Prevent or Reverse Obesity and Diabetes in Mice Expressing Human Islet Amyloid Polypeptide
Geisler, J. G., Zawalich, W. S., Zawalich, K. C., Lakey, J. R. T., Stukenbrok, H., Milici, A. J., & Soeller, W. C. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2158 · Cited by 79
Ganglioside‐induced amyloid formation by human islet amyloid polypeptide in lipid rafts
Wakabayashi, M., & Matsuzaki, K. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.07.044 · Cited by 78
The Ability of Rodent Islet Amyloid Polypeptide To Inhibit Amyloid Formation by Human Islet Amyloid Polypeptide Has Important Implications for the Mechanism of Amyloid Formation and the Design of Inhibitors
Cao, P., Meng, F., Abedini, A., & Raleigh, D. P. (2009) · Biochemistry · doi:10.1021/bi901751b · Cited by 78
Insulin secretion and insulin sensitivity in diabetic subgroups: studies in the prediabetic and diabetic state
Tripathy, D., Carlsson, X. C. L., Lehto, M. J., Isomaa, B., Tuomi, T., & Groop, L. (2000) · Diabetologia · doi:10.1007/s001250051558 · Cited by 79
The potential role of human islet amyloid polypeptide in type 2 diabetes mellitus and Alzheimer’s diseases
Alrouji, M., Al-Kuraishy, H. M., Al-Gareeb, A. I., Alexiou, A. T., Papadakis, M., Saad, ‏. M., & Batiha, G. E. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01082-1 · Cited by 81
The role of self-assembling polypeptides in building nanomaterials
Liu, L., Busuttil, K. L., Zhang, S., Yang, Y., Wang, C., Besenbacher, F., & Dong, M. (2011) · Physical Chemistry Chemical Physics · doi:10.1039/c1cp21338e · Cited by 75
Neuroendocrine hormone amylin in diabetes
Zhang, X., Pan, Y.-H., Huang, Y., & Zhao, H. (2016) · World Journal of Diabetes · doi:10.4239/wjd.v7.i9.189 · Cited by 75
Tuning the rate of aggregation of hIAPP into amyloid using small-molecule modulators of assembly
Xu, Y., Maya‐Martinez, R., Guthertz, N., Heath, G. R., Manfield, I. W., Breeze, A. L., Sobott, F., Foster, R., & Radford, S. E. (2022) · Nature Communications · doi:10.1038/s41467-022-28660-7 · Cited by 77
Residue-Specific, Real-Time Characterization of Lag-Phase Species and Fibril Growth During Amyloid Formation: A Combined Fluorescence and IR Study of p-Cyanophenylalanine Analogs of Islet Amyloid Polypeptide
Marek, P., Mukherjee, S. S., Zanni, M. T., & Raleigh, D. P. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.05.041 · Cited by 76
Interaction of hIAPP with Model Raft Membranes and Pancreatic β‐Cells: Cytotoxicity of hIAPP Oligomers
Weise, K., Radovan, D., Gohlke, A., Opitz, N., & Winter, R. (2010) · ChemBioChem · doi:10.1002/cbic.201000039 · Cited by 74
A mechanistic approach for islet amyloid polypeptide aggregation to develop anti-amyloidogenic agents for type-2 diabetes
Ahmad, E., Ahmad, A., Singh, S. P., Arshad, M., Khan, A. H., & Khan, R. H. (2011) · Biochimie · doi:10.1016/j.biochi.2010.12.012 · Cited by 74
Processing of Pro-Islet Amyloid Polypeptide in the Constitutive and Regulated Secretory Pathways of β Cells
Marzban, L., Trigo‐Gonzalez, G., & Verchere, C. B. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0407 · Cited by 74
Self-citation
β‐cell mass in people with type 2 diabetes
Cho, J., Kim, J., Shin, J., Shin, J., & Yoon, K. (2011) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2010.00072.x · Cited by 69
Islet Amyloid Development in a Mouse Strain Lacking Endogenous Islet Amyloid Polypeptide (IAPP) but Expressing Human IAPP
Westermark, G., Gebre-Medhin, S., Steiner, D., & Westermark, P. (2000) · Molecular Medicine · doi:10.1007/bf03402051 · Cited by 74
Islet redox stress: the manifold toxicities of insulin resistance, metabolic syndrome and amylin derived islet amyloid in type 2 diabetes mellitus.
Hayden, M. R., & Tyagi, S. C. (2002) · PubMed · Cited by 74
Fibrillar Islet Amyloid Polypeptide Differentially Affects Oxidative Mechanisms and Lipoprotein Uptake in Correlation with Cytotoxicity in Two Insulin-Producing Cell Lines
Janciauskiene, S. M., & Åhrén, B. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1989 · Cited by 72
Two-dimensional Infrared Spectroscopy Provides Evidence of an Intermediate in the Membrane-catalyzed Assembly of Diabetic Amyloid
Ling, Y. L., Strasfeld, D. B., Shim, S., Raleigh, D. P., & Zanni, M. T. (2009) · The Journal of Physical Chemistry B · doi:10.1021/jp810261x · Cited by 71
Contribution of the intrinsic disulfide to the assembly mechanism of islet amyloid
Koo, B. W., & Miranker, A. D. (2004) · Protein Science · doi:10.1110/ps.041051205 · Cited by 72
In vivo molecular imaging of peripheral amyloidosis using heparin-binding peptides
Wall, J. S., Richey, T., Stuckey, A. C., Donnell, R. L., Macy, S. D., Martin, E. B., Williams, A. D., Higuchi, K., & Kennel, S. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103247108 · Cited by 69
Relationship between plasma plasminogen activator inhibitor 1 and insulin resistance
Bastard, J., Pi�roni, L., & Hainque, B. (2000) · Diabetes/Metabolism Research and Reviews · doi:10.1002/1520-7560(200005/06)16:3 · Cited by 148
Hexafluoroisopropanol Induces Amyloid Fibrils of Islet Amyloid Polypeptide by Enhancing Both Hydrophobic and Electrostatic Interactions
Yanagi, K., Ashizaki, M., Yagi, H., Sakurai, K., Lee, Y., & Goto, Y. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.226688 · Cited by 69
S20G mutation of the amylin gene is associated with Type II diabetes in Japanese
Seino, S. (2001) · Diabetologia · doi:10.1007/s001250100531 · Cited by 68
Dipeptidyl Peptidase IV Inhibitors and the Incretin System in Type 2 Diabetes Mellitus
Langley, A., Suffoletta, T. J., & Jennings, H. R. (2007) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.27.8.1163 · Cited by 65
Roles of Gastrointestinal and Adipose Tissue Peptides in Childhood Obesity and Changes After Weight Loss Due to Lifestyle Intervention
Roth, C. L., & Reinehr, T. (2010) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpediatrics.2009.265 · Cited by 66
Selection for Nonamyloidogenic Mutants of Islet Amyloid Polypeptide (IAPP) Identifies an Extended Region for Amyloidogenicity
Fox, A., Snollaerts, T., Casanova, C. E., Calciano, A., Nogaj, L. A., & Moffet, D. A. (2010) · Biochemistry · doi:10.1021/bi100337p · Cited by 67
In vivo aggregation of a single enzyme limits growth of Escherichia coli at elevated temperatures
Gur, E., Biran, D., Gazit, E., & Ron, E. Z. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.03257.x · Cited by 66
Role of Carboxypeptidase E in Processing of Pro-Islet Amyloid Polypeptide in β-Cells
Marzban, L., Soukhatcheva, G., & Verchere, C. B. (2004) · Endocrinology · doi:10.1210/en.2004-1175 · Cited by 65
Self-citation
Simultaneous Monitoring of Insulin and Islet Amyloid Polypeptide Secretion from Islets of Langerhans on a Microfluidic Device
Lomasney, A. R., Yi, L., & Roper, M. G. (2013) · Analytical Chemistry · doi:10.1021/ac401625g · Cited by 64
Involvement of SSAO-mediated deamination in adipose glucose transport and weight gain in obese diabetic KKAy mice
Yu, P. H., Wang, M. S., Fan, H. J., Deng, Y., & Gubisne-Haberle, D. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00272.2003 · Cited by 64
Fas-Associated Death Receptor Signaling Evoked by Human Amylin in Islet β-Cells
Zhang, S., Liu, H., Yu, H., & Cooper, G. J. S. (2007) · Diabetes · doi:10.2337/db07-0849 · Cited by 63
Crystal Structures of IAPP Amyloidogenic Segments Reveal a Novel Packing Motif of Out-of-Register Beta Sheets
Soriaga, A. B., Sangwan, S., Macdonald, R., Sawaya, M. R., & Eisenberg, D. S. (2015) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.5b09981 · Cited by 62
MCP-1 Upregulates Amylin Expression in Murine Pancreatic β Cells through ERK/JNK-AP1 and NF-κB Related Signaling Pathways Independent of CCR2
Cai, K., Qi, D., Hou, X., Wang, O., Chen, J., Deng, B., Qian, L., Liu, X., & Le, Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019559 · Cited by 65
Increased Expression and Activation of c-Jun Contributes to Human Amylin-induced Apoptosis in Pancreatic Islet β-Cells
Zhang, S., Liu, J., MacGibbon, G. A., Dragunow, M., & Cooper, G. J. S. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)01044-6 · Cited by 62
Mutational Analysis of the Ability of Resveratrol To Inhibit Amyloid Formation by Islet Amyloid Polypeptide: Critical Evaluation of the Importance of Aromatic–Inhibitor and Histidine–Inhibitor Interactions
Tu, L., Young, L. M., Wong, A. G., Ashcroft, A. E., Radford, S. E., & Raleigh, D. P. (2014) · Biochemistry · doi:10.1021/bi501016r · Cited by 61
Involvement of cerebrovascular semicarbazide-sensitive amine oxidase in the pathogenesis of Alzheimer’s disease and vascular dementia
Yu, P. H. (2001) · Medical Hypotheses · doi:10.1054/mehy.2001.1329 · Cited by 61
Antioxidant treatment may protect pancreatic beta cells through the attenuation of islet fibrosis in an animal model of type 2 diabetes
Lee, E., Ryu, G. R., Ko, S., Ahn, Y., Yoon, K., Ha, H., & Song, K. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.09.087 · Cited by 60
Fructose-1,6-Bisphosphatase Overexpression in Pancreatic β-Cells Results in Reduced Insulin Secretion
Kebede, M. A., Favaloro, J. M., Gunton, J. E., Laybutt, D. R., Shaw, M., Wong, N., Fam, B. C., Aston‐Mourney, K., Rantzau, C., Zulli, A., et al. (2008) · Diabetes · doi:10.2337/db07-1326 · Cited by 59
Self-citation
NFGAIL Amyloid Oligomers: The Onset of Beta-Sheet Formation and the Mechanism for Fibril Formation
Hoffmann, W., Folmert, K., Moschner, J., Huang, X., von Berlepsch, H., Koksch, B., Bowers, M. T., von Helden, G., & Pagel, K. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b09510 · Cited by 60
An autophagy enhancer ameliorates diabetes of human IAPP-transgenic mice through clearance of amyloidogenic oligomer
Kim, J., Park, K., Kim, M. J., Lim, H. J., Kim, K. H., Kim, S., Lee, E., Kim, S., Kim, S. J., Hur, K. Y., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20454-z · Cited by 62
Islet amyloid polypeptide in the islets of Langerhans: friend or foe?
Gebré‐Medhin, S., Olofsson, C. S., & Mulder, H. (2000) · Diabetologia · doi:10.1007/s001250051364 · Cited by 60
Amide inequivalence in the fibrillar assembly of islet amyloid polypeptide
Koo, B. W., Hebda, J. A., & Miranker, A. D. (2008) · Protein Engineering Design and Selection · doi:10.1093/protein/gzm076 · Cited by 60
The Potential for Stem Cell Therapy in Diabetes
Meier, J. J., Bhushan, A., & Butler, P. C. (2006) · Pediatric Research · doi:10.1203/01.pdr.0000206857.38581.49 · Cited by 60
Membrane disordering is not sufficient for membrane permeabilization by islet amyloid polypeptide: studies of IAPP(20–29) fragments
Brender, J., Heyl, D., Samisetti, S., Kotler, S. A., Osborne, J. M., Pesaru, R. R., & Ramamoorthy, A. (2013) · Physical Chemistry Chemical Physics · doi:10.1039/c3cp44696d · Cited by 59
The islet amyloid polypeptide (amylin) gene S20G mutation in Chinese subjects: Evidence for associations with type 2 diabetes and cholesterol levels
Lee, S. C., Hashim, Y., Li, J. K. Y., Ko, G. T. C., Critchley, J., Cockram, C. S., & Chan, J. C. N. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01244.x · Cited by 59
Small Interfering RNA–Mediated Suppression of Proislet Amyloid Polypeptide Expression Inhibits Islet Amyloid Formation and Enhances Survival of Human Islets in Culture
Marzban, L., Tomás, A., Becker, T. C., Rosenberg, L. C., Oberholzer, J., Fraser, P. E., Halban, P. A., & Verchere, C. B. (2008) · Diabetes · doi:10.2337/db08-0485 · Cited by 57
Self-citation
Analysis of insulin amyloid fibrils by Raman spectroscopy
Ortiz, C., Zhang, D., Ribbe, A. E., Xie, Y. Q., & Ben‐Amotz, D. (2007) · Biophysical Chemistry · doi:10.1016/j.bpc.2007.03.012 · Cited by 57
Involvement of TGF-β and Autophagy Pathways in Pathogenesis of Diabetes: A Comprehensive Review on Biological and Pharmacological Insights
Heydarpour, F., Sajadimajd, S., Mirzarazi, E., Haratipour, P., Joshi, T., Farzaei, M. H., Khan, H., & Echeverría, J. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.498758 · Cited by 57
Minireview: Emerging Concepts in Islet Macrophage Biology in Type 2 Diabetes
Morris, D. L. (2015) · Molecular Endocrinology · doi:10.1210/me.2014-1393 · Cited by 57
The chaperone proteins HSP70, HSP40/DnaJ and GRP78/BiP suppress misfolding and formation of β-sheet-containing aggregates by human amylin: a potential role for defective chaperone biology in Type 2 diabetes
Chien, V., Aitken, J. F., Zhang, S., Buchanan, C. M., Hickey, A. J., Brittain, T., Cooper, G. J. S., & Loomes, K. M. (2010) · Biochemical Journal · doi:10.1042/bj20100434 · Cited by 54
Inhibition of glycosaminoglycan synthesis and protein glycosylation with WAS-406 and azaserine result in reduced islet amyloid formation in vitro
Hull, R. L., Zraika, S., Udayasankar, J., Kisilevsky, R., Szarek, W. A., Wight, T. N., & Kahn, S. E. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00208.2007 · Cited by 53
Self-citation
Myricetin Inhibits Islet Amyloid Polypeptide (IAPP) Aggregation and Rescues Living Mammalian Cells from IAPP Toxicity
Zelus, C., Fox, A., Calciano, A., Faridian, B. S., Nogaj, L. A., & Moffet, D. A. (2012) · The Open Biochemistry Journal · doi:10.2174/1874091x01206010066 · Cited by 53
"A" is for amylin and amyloid in type 2 diabetes mellitus.
Hayden, M. R., & Tyagi, S. C. (2001) · PubMed · Cited by 52
The cerebral proteopathies
Walker, L. C., & LeVine, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00160-3 · Cited by 51
The Sulfated Triphenyl Methane Derivative Acid Fuchsin Is a Potent Inhibitor of Amyloid Formation by Human Islet Amyloid Polypeptide and Protects against the Toxic Effects of Amyloid Formation
Meng, F., Abedini, A., Plesner, A., Middleton, C. T., Potter, K. J., Zanni, M. T., Verchere, C. B., & Raleigh, D. P. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.05.001 · Cited by 53
Self-citation
Remission of Diabetes Mellitus in Cats with Diabetic Ketoacidosis
Sieber‐Ruckstuhl, N. S., Kley, S., Tschuor, F., Zini, E., Ohlerth, S. M., Boretti, F. S., & Reusch, C. E. (2008) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.2008.0201.x · Cited by 50
Direct measurement of islet amyloid polypeptide fibrillogenesis by mass spectrometry
Larson, J. L., Ko, E. C., & Miranker, A. D. (2000) · Protein Science · doi:10.1110/ps.9.2.427 · Cited by 49
Combination of Kinetically Selected Inhibitors in Trans Leads to Highly Effective Inhibition of Amyloid Formation
Meng, F., Raleigh, D. P., & Abedini, A. (2010) · Journal of the American Chemical Society · doi:10.1021/ja1046186 · Cited by 50
Structural Basis for the Inhibition of Truncated Islet Amyloid Polypeptide Aggregation by Cu(II): Insights into the Bioinorganic Chemistry of Type II Diabetes
Rivillas-Acevedo, L. A., Sánchez‐López, C., Amero, C., & Quintanar, L. (2015) · Inorganic Chemistry · doi:10.1021/ic502945k · Cited by 48
Short Peptides as Inhibitors of Amyloid Aggregation
Neddenriep, B., Calciano, A., Conti, D. J., Sauve, E., Paterson, M., Bruno, E., & Moffet, D. A. (2011) · The Open Biotechnology Journal · doi:10.2174/1874070701105010039 · Cited by 49
Profiling the Serum Protein Corona of Fibrillar Human Islet Amyloid Polypeptide
Pilkington, E. H., Gustafsson, O., Xing, Y., Hernandez-Fernaud, J. R., Zampronio, C. G., Käkinen, A., Faridi, A., Ding, F., Wilson, P., Ke, P. C., et al. (2018) · ACS Nano · doi:10.1021/acsnano.8b02346 · Cited by 47
The pathogenic mechanism of diabetes varies with the degree of overexpression and oligomerization of human amylin in the pancreatic islet β cells
Zhang, S., Liu, H., Chuang, C.-L., Li, X., Au, M., Zhang, L., Phillips, A. R. J., Scott, D. W., & Cooper, G. J. S. (2014) · The FASEB Journal · doi:10.1096/fj.14-251744 · Cited by 46
Acidic pH retards the fibrillization of human islet amyloid polypeptide due to electrostatic repulsion of histidines
Li, Y., Xu, W., Mu, Y., & Zhang, J. Z. H. (2013) · The Journal of Chemical Physics · doi:10.1063/1.4817000 · Cited by 46
Insulin Receptor Substrate-2 (Irs2) in Endothelial Cells Plays a Crucial Role in Insulin Secretion
Hashimoto, S., Kubota, N., Satō, H., Sasaki, M., Takamoto, I., Kubota, T., Nakaya, K., Noda, M., Ueki, K., & Kadowaki, T. (2014) · Diabetes · doi:10.2337/db14-0432 · Cited by 46
Heme Bound Amylin: Spectroscopic Characterization, Reactivity, and Relevance to Type 2 Diabetes
Mukherjee, S., & Dey, S. G. (2013) · Inorganic Chemistry · doi:10.1021/ic4001413 · Cited by 46
Observation of Reduced Cytotoxicity of Aggregated Amyloidogenic Peptides with Chaperone-like Molecules
Liu, L., Zhang, L., Niu, L., Xu, M., Mao, X., Yang, Y., & Wang, C. (2011) · ACS Nano · doi:10.1021/nn201773x · Cited by 46
The cat as a model for human nutrition and disease
Hoenig, M. E. (2006) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000241668.30761.69 · Cited by 45
Molecular mechanisms of membrane-associated amyloid aggregation: Computational perspective and challenges
Press‐Sandler, O., & Miller, Y. (2018) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2018.03.014 · Cited by 45
Membranes as modulators of amyloid protein misfolding and target of toxicity
Rawat, A., Langen, R., & Varkey, J. (2018) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2018.04.011 · Cited by 46
beta-cell glucokinase deficiency and hyperglycemia are associated with reduced islet amyloid deposition in a mouse model of type 2 diabetes.
Andrikopoulos, S., Verchere, C. B., Terauchi, Y., Kadowaki, T., & Kahn, S. E. (2000) · Diabetes · doi:10.2337/diabetes.49.12.2056 · Cited by 44
Self-citation
Peptide–Protein Interactions: From Drug Design to Supramolecular Biomaterials
Caporale, A., Adorinni, S., Lamba, D., & Saviano, M. (2021) · Molecules · doi:10.3390/molecules26051219 · Cited by 45
The Fluorescent Amino Acid p‐Cyanophenylalanine Provides an Intrinsic Probe of Amyloid Formation
Marek, P., Gupta, R., & Raleigh, D. P. (2008) · ChemBioChem · doi:10.1002/cbic.200800052 · Cited by 43
The Role of Autophagy in Systemic Metabolism and Human-Type Diabetes.
Kim, J., Lim, Y.-M., & Lee, M. (2018) · PubMed Central · doi:10.14348/molcells.2018.2228 · Cited by 44
Date palm (Phoenix dactylifera L.) fruit's polyphenols as potential inhibitors for human amylin fibril formation and toxicity in type 2 diabetes
Châari, A., Abdellatif, B., Nabi, F., & Khan, R. H. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.08.080 · Cited by 43
Self‐Assembling Pathway of HiApp Fibrils within Lipid Bilayers
Scalisi, S., Sciacca, M. F. M., Zhavnerko, G., Grasso, D., Marletta, G., & Rosa, C. L. (2010) · ChemBioChem · doi:10.1002/cbic.201000090 · Cited by 42
Insulin resistance and β‐cell function – a clinical perspective
Matthews, D. R. (2001) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2001.00029.x · Cited by 42
Proteoglycans synthesized and secreted by pancreatic islet β-cells bind amylin
Potter‐Perigo, S., Hull, R. L., Tsoi, C., Braun, K. R., Andrikopoulos, S., Teague, J. C., Verchere, C. B., Kahn, S. E., & Wight, T. N. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(03)00116-4 · Cited by 41
Self-citation
Characterisation of the Structure and Oligomerisation of Islet Amyloid Polypeptides (IAPP): A Review of Molecular Dynamics Simulation Studies
Moore, S. J., Sonar, K., Bharadwaj, P., Deplazes, E., & Mancera, R. L. (2018) · Molecules · doi:10.3390/molecules23092142 · Cited by 41
Human islet amyloid polypeptide (hIAPP) aggregation in type 2 diabetes: Correlation between intrinsic physicochemical properties of hIAPP aggregates and their cytotoxicity
Châari, A., & Ladjimi, M. M. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.06.050 · Cited by 41
Heparan Sulfate Proteoglycans in Amyloidosis
Zhang, X. L., & Li, J. (2010) · Progress in molecular biology and translational science · doi:10.1016/s1877-1173(10)93013-5 · Cited by 41
Formation of a Stable Oligomer of β-2 Microglobulin Requires only Transient Encounter with Cu(II)
Calabrese, M. F., & Miranker, A. D. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.12.034 · Cited by 41
Amyloid fibril formation is progressive and correlates with beta-cell secretion in transgenic mouse isolated islets
MacArthur, D. L. A., de Koning, E. J. P., Verbeek, J. S., Morris, J. F., & Clark, A. (1999) · Diabetologia · doi:10.1007/s001250051295 · Cited by 40
Conformation-Dependent Manipulation of Human Islet Amyloid Polypeptide Fibrillation by Shiitake-Derived Lentinan
Xin, Y., Wang, X., Luo, L., & Meng, F. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b11078 · Cited by 40
Diabetes: Magnitude and Mechanisms
Fowler, M. J. (2010) · Clinical Diabetes · doi:10.2337/diaclin.28.1.42 · Cited by 41

Authors: Kahn, S. E., Andrikopoulos, S., & Verchere, C. B.
Affiliations: University of Washington (US)
ORCID: Kahn, S E
Verchere, C B
Venue: Diabetes
Publisher: American Diabetes Association
Published: 1999-02-01
Volume: 48
Issue: 2
Pages: 241-253
ISSN: 0012-1797 (ISSN-L)
1939-327X
DOI: 10.2337/diabetes.48.2.241
OpenAlex: W1992231742
Cited by: 488
References: 0
Citations by year: 2026: 8 · 2025: 8 · 2024: 9 · 2023: 10 · 2022: 16 · 2021: 11 · 2020: 15 · 2019: 13 · 2018: 24 · 2017: 12 · 2016: 18 · 2015: 17 · 2014: 21 · 2013: 17 · 2012: 25
FWCI: 24.90
Type: journal article
Language: en
Open access: closed
Locations: Diabetes (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute of Diabetes and Digestive and Kidney Diseases (R01DK050703, DK48152, DK50703, R01DK048152, DK-17047, P30DK017047)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords: islet amyloid, type 2 diabetes, amylin, beta-cell function, amyloid fibril formation, apolipoprotein E, perlecan, dietary fat, hyperglycemia, beta-cell mass loss, amyloidogenesis
MeSH terms: Amyloid, Amyloidosis, Animals, Diabetes Mellitus, Type 2, Dietary Fats, Humans, Islets of Langerhans, Islet Amyloid Polypeptide

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks